Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating 16 and 24 Weeks of Response Guided Therapy With GS-9190, GS-9256, Ribavirin (Copegus) and Peginterferon Alfa 2a (Pegasys) in Treatment Na�ve Subjects with Chronic Genotype 1 Hepatitis C Virus Infection https://kusajili.com:443/Trial/04ySAJYGxEiarR0nvOe1kg%24a-phase-2b-randomized-double-blind-placebo-controlled-trial-evaluating-16-and-24-weeks-of-response-guided-therapy-with-gs-9190-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message